tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (DE:30O)
FRANKFURT:30O
Advertisement

OncoTherapy Science (30O) Revenue

Compare
0 Followers

OncoTherapy Science Revenue

OncoTherapy Science had a revenue of 186.75M in the quarter ending Mar 31, 2025, with -44.75%. This bring the company's revenue in the last twelve months to 749.75M, Decreased 6.03%. In the fiscal year ending Dec 31, 2024, OncoTherapy Science had annual revenue of 750.05M with 22.93% growth.
Revenue (ttm)
749.75M
Revenue Growth
P/S Ratio
0.06
Revenue/Employee
€13,889,778
Employees
54
Market Cap
€46.47M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
750.05M139.93M+122.93%
Dec 31, 2023
610.12M-524.78M+53.76%
Dec 31, 2022
1.13B-18.76M+98.37%
Dec 31, 2021
1.15B821.19M+346.99%
Dec 31, 2020
332.48M16.26M+105.14%
Dec 31, 2019
316.21M35.63M+112.70%
Dec 31, 2018
280.59M69.33M+132.82%
Dec 31, 2017
211.25M-75.42M+73.69%
Dec 31, 2016
286.67M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis